marimastat has been researched along with Colorectal Cancer in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Afshar, S; Bahreini, F; Mortezapour, M; Najafi, R; Tapak, L | 1 |
| King, J; Morris, DL; North, H | 1 |
| Yamada, K; Yamaguchi, S; Yamamura, T | 1 |
| McCann, PP; Rasmussen, HS | 1 |
| Baillet, M; Barker, K; Berrington, A; Bleiberg, H; Brown, PD; Daniel, F; Johnson, PW; Lynch, KP; Mansi, JL; Millar, AW; Neoptolemos, JP; Primrose, JN; Seymour, M; Van Belle, S | 1 |
| Brown, PD | 1 |
| Ichikawa, Y; Ishikawa, T; Shimada, H; Tanaka, K; Togo, S | 1 |
3 review(s) available for marimastat and Colorectal Cancer
| Article | Year |
|---|---|
[Angiogenesis and metastasis in colorectal cancer].
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Colorectal Neoplasms; Enzyme Inhibitors; Gefitinib; Humans; Hydroxamic Acids; Metalloendopeptidases; Neoplasm Metastasis; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Quinazolines; Vascular Endothelial Growth Factor A | 2003 |
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes | 1997 |
[Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
Topics: Colorectal Neoplasms; Enzyme Inhibitors; Extracellular Matrix; Humans; Hydroxamic Acids; Liver Neoplasms; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Plasminogen Activators | 2001 |
2 trial(s) available for marimastat and Colorectal Cancer
| Article | Year |
|---|---|
Effect of marimastat on serum tumour markers in patients with colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 2000 |
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Muscle, Skeletal; Pilot Projects; Recurrence | 1999 |
3 other study(ies) available for marimastat and Colorectal Cancer
| Article | Year |
|---|---|
Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.
Topics: Bevacizumab; Biomarkers; Colorectal Neoplasms; Curcumin; Gene Regulatory Networks; Humans; Matrix Metalloproteinase 9; Microbial Collagenase; MicroRNAs | 2023 |
Marimastat. BB 2516, TA 2516.
Topics: Adult; Antineoplastic Agents; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Hydroxamic Acids; Male; Melanoma; Metalloendopeptidases; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Protease Inhibitors; Stomach Neoplasms | 1999 |
Ongoing trials with matrix metalloproteinase inhibitors.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Enzyme Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Organic Chemicals; Phenylbutyrates | 2000 |